This study evaluates whether β-blockers were associated with a reduction in cardiovascular events or angina after Coronary Artery Bypass Graft (CABG) surgery, in otherwise stable low-risk patients during a mid-term follow-up.
This review summarizes a systematic analysis of 216 randomized trials of cardiovascular interventions performed during 2008–2019, according to the source of trial funding.